|
MIPOL1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.84809994979918E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.17040052596928E-10 |
| Normal-vs-Stage2 |
3.717999999997E-05 |
| Normal-vs-Stage3 |
1.197430E-03 |
| Normal-vs-Stage4 |
6.658500E-02 |
| Stage1-vs-Stage2 |
7.294000E-01 |
| Stage1-vs-Stage3 |
5.725800E-02 |
| Stage1-vs-Stage4 |
1.939640E-01 |
| Stage2-vs-Stage3 |
3.242600E-01 |
| Stage2-vs-Stage4 |
4.418400E-01 |
| Stage3-vs-Stage4 |
9.672400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.71630001719348E-09 |
| Normal-vs-AfricanAmerican |
4.03669999982093E-07 |
| Normal-vs-Asian |
9.039800E-03 |
| Caucasian-vs-AfricanAmerican |
7.519000E-01 |
| Caucasian-vs-Asian |
7.044800E-01 |
| AfricanAmerican-vs-Asian |
7.472000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.67323965583455E-12 |
| Normal-vs-Female |
1.660330E-03 |
| Male-vs-Female |
8.238100E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.39700000246057E-08 |
| Normal-vs-Extreme_Weight |
1.66589997352418E-09 |
| Normal-vs-Obese |
3.564900E-04 |
| Normal-vs-Extreme_Obese |
7.8143000000086E-05 |
| Normal_Weight-vs-Extreme_Weight |
4.589000E-01 |
| Normal_Weight-vs-Obese |
1.218380E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.303400E-01 |
| Extreme_Weight-vs-Obese |
2.315600E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.651200E-01 |
| Obese-vs-Extreme_Obese |
2.700000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.146000E-01 |
| Normal-vs-Age(41-60Yrs) |
7.32039999729039E-08 |
| Normal-vs-Age(61-80Yrs) |
3.13730152967651E-11 |
| Normal-vs-Age(81-100Yrs) |
3.70339999999914E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.649800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.848300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.548430E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.264100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.527590E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.626000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.61429980494177E-10 |
| Normal-VS-Type2 PRCC |
1.00329744512351E-11 |
| Normal-VS-KIRP CIMP |
5.947000E-01 |
| Normal-VS-Unclassified PRCC |
1.216150E-04 |
| Type1 PRCC-VS-Type2 PRCC |
7.374000E-02 |
| Type1 PRCC-VS-KIRP CIMP |
5.175500E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.822600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.059800E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
5.893700E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
8.051800E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.70759970000256E-10 |
| Normal-vs-N1 |
3.056600E-01 |
| Normal-vs-N2 |
9.65889999999803E-05 |
| N0-vs-N1 |
1.285570E-02 |
| N0-vs-N2 |
2.644200E-01 |
| N1-vs-N2 |
9.976400E-02 |
|
|
